Willmar Regional Cancer Center (through Rice Memorial Hospital) belongs to the Metro Minnesota Community Research Consortium (MMCORC) , a non-profit research program sponsored by the National Cancer Institute (NCI).
The CCOP network conducts clinical trials for cancer prevention, treatment, and control, which includes symptom management, toxicity reduction, supportive and palliative care, and quality of life research.
Since its inception in 1983, the MMCORC has linked community cancer specialists, primary care physicians and other health care professionals to NCI-approved research studies, called clinical trials. In our community, over 200 patients per year are enrolled in NCI-sponsored treatment studies, and another 300 patients per year participate in NCI cancer prevention and symptom management studies through the MMCORC.
Benefits of the MMCORC
Cancer clinical trials are the way we make progress against cancer. Physicians participating with the MMCORC have access to the newest advances in cancer research.
Advances in the prevention and treatment of cancer and controlling the side effects of cancer treatment depend on information gained from well-conducted national clinical trials. Improvements in survival and prevention for many types of cancer are due to the widespread acceptance of treatment advances confirmed in clinical trials.
Reasons Why People Take Part in Clinical Trials
- To receive a new treatment for their cancer.
- To receive a new treatment to manage the side effects of their cancer treatment.
- To participate in new methods to prevent or detect cancer.
- To contribute to the medical knowledge for improving cancer care and helping future patients.
Learn more about:
MMCORC
Clinical Trials and Resources
National Cancer Institute